Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2009 1
2011 1
2020 1
2021 8
2022 11
2023 6
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Results by year

Filters applied: . Clear all
Page 1
Reducing length of hospital stay with colchicine.
Karakaş Ö, Erden A, Güven SC, Armağan B, Sahiner ES, Kurtipek AC, Inan O, Gemcioglu E, Ateş İ, Omma A, Küçüksahin O. Karakaş Ö, et al. J Infect Dev Ctries. 2022 Jan 31;16(1):57-62. doi: 10.3855/jidc.14924. J Infect Dev Ctries. 2022. PMID: 35192522 Free article.
Low relapse rate in patients with giant cell arteritis in a multi-centre retrospective Turkish Registry.
Alibaz-Öner F, Kelesoglu B, Balci MA, Yardimci GK, Armağan B, Kiliç L, Karakaş Ö, Erden A, Yasar Bilge S, Kardaş RC, Küçük H, Zengin O, Tasci M, Kocaer SB, Yavuz S, Dogru A, Şahin M, Bayindir O, Sevik G, Ertürk Z, Alpay-Kanitez N, Gogebakan H, Tezcan ME, Oksuz MF, Cefle A, Kucuksahin O, Yazici A, Kasapoglu E, Bes C, Unal AU, Dalkiliç E, Yildirim Çetin G, Aksu K, Keser G, Onen F, Çobankara V, Kisacik B, Onat AM, Öztürk MA, Kaşifoğlu T, Omma A, Karadag O, Ates A, Direskeneli H. Alibaz-Öner F, et al. Among authors: karakas o. Clin Exp Rheumatol. 2024 Apr;42(4):816-821. doi: 10.55563/clinexprheumatol/zr7s0g. Epub 2023 Nov 15. Clin Exp Rheumatol. 2024. PMID: 37976117 Free article.
A single center experience of intravenous immunoglobulin treatment in Covid-19.
Omma A, Erden A, Armağan B, Güven SC, Karakaş Ö, Şahiner ES, Erdem D, İzdeş S, Ateş İ, Küçükşahin O. Omma A, et al. Among authors: karakas o. Int Immunopharmacol. 2021 Sep;98:107891. doi: 10.1016/j.intimp.2021.107891. Epub 2021 Jun 14. Int Immunopharmacol. 2021. PMID: 34153671 Free PMC article.
Safety and immunogenicity of inactive vaccines as booster doses for COVID-19 in Türkiye: A randomized trial.
Omma A, Batirel A, Aydin M, Yilmaz Karadag F, Erden A, Kucuksahin O, Armagan B, Güven SC, Karakas O, Gokdemir S, Altunal LN, Buber AA, Gemcioglu E, Zengin O, Inan O, Sahiner ES, Korukluoglu G, Sezer Z, Ozdarendeli A, Kara A, Ates I. Omma A, et al. Among authors: karakas o. Hum Vaccin Immunother. 2022 Nov 30;18(6):2122503. doi: 10.1080/21645515.2022.2122503. Epub 2022 Oct 31. Hum Vaccin Immunother. 2022. PMID: 36315843 Free PMC article. Clinical Trial.
Comparison of anakinra and tocilizumab in management of severe COVID-19: a retrospective cohort study.
Küçükşahin O, Erden A, Karakaş Ö, Güven SC, Armağan B, Şahiner EŞ, İnan O, Kurtipek AC, Gemcioğlu E, Karaahmetoğlu S, Turan S, İzdeş S, Erdem D, Aypak A, Ayhan M, Akıncı E, Bodur H, Güner R, Omma A, Ateş İ. Küçükşahin O, et al. Among authors: karakas o. Turk J Med Sci. 2022 Oct;52(5):1486-1494. doi: 10.55730/1300-0144.5487. Epub 2022 Oct 19. Turk J Med Sci. 2022. PMID: 36422492 Free PMC article.
A single-center COVID-19 vaccine experience with CoronaVac and BNT162b2 in familial Mediterranean fever patients.
Güven SC, Karakaş Ö, Atalar E, Konak HE, Akyüz Dağlı P, Kayacan Erdoğan E, Armağan B, Gök K, Doğan İ, Maraş Y, Erden A, Erten Ş, Küçükşahin O, Omma A. Güven SC, et al. Among authors: karakas o. Int J Rheum Dis. 2022 Jul;25(7):787-794. doi: 10.1111/1756-185X.14349. Epub 2022 Jun 1. Int J Rheum Dis. 2022. PMID: 35642453 Free PMC article.
28 results